AVITA Medical to Host Investor Webinar Briefing
August 14, 2023 08:00 ET
|
AVITA Medical
VALENCIA, Calif., Aug. 14, 2023 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a regenerative medicine company leading the development and commercialization of first-in-class...
AVITA Medical Reports Second Quarter Financial Results
August 10, 2023 16:01 ET
|
AVITA Medical
VALENCIA, Calif., Aug. 10, 2023 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH) (the “Company”), a regenerative medicine company leading the development and commercialization of...
AVITA Medical to Announce Second Quarter 2023 Financial Results
July 20, 2023 16:05 ET
|
AVITA Medical
VALENCIA, Calif., July 20, 2023 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a regenerative medicine company leading the development and commercialization of first-in-class...
AVITA Medical Submits FDA PMA Supplement for RECELL GO
June 29, 2023 18:21 ET
|
AVITA Medical
VALENCIA, Calif., June 29, 2023 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a regenerative medicine company leading the development and commercialization of first-in-class...
AVITA Medical Rejoins the Russell 3000 Index
June 26, 2023 08:00 ET
|
AVITA Medical
VALENCIA, Calif., and MELBOURNE, Australia, June 26, 2023 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a regenerative medicine company leading the development and...
AVITA Medical Announces FDA Approval of RECELL for Skin Repigmentation in Vitiligo Patients
June 16, 2023 14:47 ET
|
AVITA Medical
VALENCIA, Calif. and MELBOURNE, Australia, June 16, 2023 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a regenerative medicine company leading the development and...
AVITA Medical Announces Appointment of David O’Toole as Chief Financial Officer
June 15, 2023 16:05 ET
|
AVITA Medical
VALENCIA, Calif. and MELBOURNE, Australia, June 15, 2023 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a regenerative medicine company leading the development and...
AVITA Medical Announces FDA Approval of RECELL for Treatment of Full-Thickness Skin Defects
June 07, 2023 20:00 ET
|
AVITA Medical
VALENCIA, Calif. and MELBOURNE, Australia, June 07, 2023 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a regenerative medicine company leading the development and...
AVITA Medical to Host Investor Webinar Briefing
May 15, 2023 18:31 ET
|
AVITA Medical
VALENCIA, Calif. and MELBOURNE, Australia, May 15, 2023 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a regenerative medicine company leading the development and...
AVITA Medical Reports First Quarter Financial Results and Affirms Full Year Guidance
May 11, 2023 16:12 ET
|
AVITA Medical
VALENCIA, Calif. and MELBOURNE, Australia, May 11, 2023 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH) (the “Company”), a regenerative medicine company leading the development and...